Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils AI Age-Based Health Risk Estimator Targeting $1 Trillion Digital Health Market by 2030

Rhea-AI Summary

Medical Care Technologies (OTC PINK:MDCE) has unveiled its AI Facial Age-Based Health Risk Estimator, an innovative technology that analyzes facial features to predict health risks and biological age. The system utilizes advanced analysis of micro-wrinkle density, skin elasticity, and tonal gradients to generate real-time health insights.

The company is targeting the digital health and longevity market, which is projected to reach $1 trillion globally by 2030. The technology will be integrated into MDCE's beta app, scheduled for release in 2026. CEO Marshall Perkins III emphasized the technology's potential to revolutionize preventative healthcare and wellness management.

Positive

• Targeting rapidly growing digital health market projected to reach $1 trillion by 2030
• Innovative non-invasive diagnostic technology with potential applications for insurers and healthcare providers
• Beta app launch planned for 2026, indicating clear product roadmap

Negative

• Product still in development phase with beta release not until 2026
• Faces regulatory and market adoption uncertainties as mentioned in Safe Harbor statement
• Operating in highly competitive digital health space with established players

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MESA, ARIZONA / ACCESS Newswire / September 5, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today unveiled its AI Facial Age-Based Health Risk Estimator, a breakthrough technology that uses facial imaging to deliver predictive health insights.

The system leverages micro-wrinkle density, skin elasticity, and tonal gradient analysis to generate real-time estimates of biological age and chronic disease predisposition. By combining facial biometrics with predictive AI health markers, MDCE aims to redefine preventative diagnostics and consumer health optimization.

This innovative tool addresses the fast-growing digital health and longevity market, projected to exceed $1 trillion globally by 2030, as consumers and providers alike seek personalized, non-invasive diagnostic technologies.

"Our Age-Based Risk Estimator has the power to transform how people think about wellness and preventative healthcare," said CEO Marshall Perkins III. "It offers actionable insights that could change how insurers, providers, and individuals manage long-term health."

This technology will also be featured in MDCE's beta app release scheduled for 2026.

For more information visit: https://medicalcaretechnologies.com

Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of federal securities laws. Actual results may differ materially due to risks and uncertainties, including market conditions, regulatory approvals, and product development timelines. Medical Care Technologies Inc. undertakes no obligation to update these statements except as required by law.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What is MDCE's new AI Facial Age-Based Health Risk Estimator?

It's an AI-powered technology that analyzes facial features including micro-wrinkle density, skin elasticity, and tonal gradients to estimate biological age and predict potential health risks.

When will Medical Care Technologies (MDCE) release their health risk estimator app?

MDCE plans to release a beta version of the app in 2026.

What is the market potential for MDCE's health risk estimation technology?

The technology targets the digital health and longevity market, which is projected to exceed $1 trillion globally by 2030.

How does MDCE's AI health risk estimator work?

The system uses facial biometrics and AI analysis to examine micro-wrinkle density, skin elasticity, and tonal gradients, providing real-time estimates of biological age and disease predisposition.

What are the potential applications of MDCE's health risk estimation technology?

The technology can be used by insurers, healthcare providers, and individuals for preventative healthcare and wellness management.